Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Lyketsos

Showing results (231-240 of 396) with videos related to

Pageof 40
Sort By:
Journal of the American Medical Directors Association|June 6, 2009
Correlates of functional dependence among recently admitted assisted living residents with and without dementiaQuincy M Samus, Lawrence Mayer, Chiadi U Onyike, et al.
Journal of Alzheimer'S Disease : JAD|December 8, 2015
Empirically Defining Trajectories of Late-Life Cognitive and Functional DeclineHelen Hochstetler, Paula T Trzepacz, Shufang Wang, et al.
Journal of Applied Gerontology : the Official Journal of the Southern Gerontological Society|February 23, 2023
Economic Analysis of the Tailored Activity Program: A Nonpharmacological Approach to Improve Quality of Life in People Living With Dementia and their CaregiversLaura T Pizzi, Katherine M Prioli, Eric Jutkowitz, et al.
Schizophrenia Bulletin|June 2, 2025
Screening for Cognitive Decline in Psychotic Disorders in Midlife: Examining Scoring the Clinical Dementia Rating Using Longitudinal DataSean A P Clouston, Katherine Jonas, Constantine G Lyketsos, et al.
Alzheimer'S & Dementia (New York, N. Y.)|July 14, 2026
Heterogeneous responses to memantine in Alzheimer's disease: A precision medicine approach using iPSC modelsCristina Zivko, Ram Sagar, Waqar Ahmed, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|September 29, 2015
Oral glucose tolerance testing to modulate plasma amyloid levels: A novel biomarkerEsther S Oh, Christopher M Marano, Jeannie-Marie Leoutsakos, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|January 25, 2013
Systematic review of the effectiveness of pharmacologic interventions to improve quality of life and well-being in people with dementiaClaudia Cooper, Naaheed Mukadam, Cornelius Katona, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 6, 2011
Neuropsychiatric symptoms in Alzheimer's diseaseConstantine G Lyketsos, Maria C Carrillo, J Michael Ryan, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|June 13, 2019
Neuropsychiatric Symptoms as Risk Factors for Cognitive Decline in Clinically Normal Older Adults: The Cache County StudyMuhammad Haroon Burhanullah, JoAnn T Tschanz, Matthew E Peters, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|September 9, 2004
Cognitive response to pharmacological treatment for depression in Alzheimer disease: secondary outcomes from the depression in Alzheimer's disease study (DIADS)Cynthia A Munro, Jason Brandt, Jeannie-Marie E Sheppard, et al.
Pageof 40

Showing results (231-240 of 396) with videos related to

Sort By:
Pageof 40
Journal of the American Medical Directors Association|June 6, 2009
Correlates of functional dependence among recently admitted assisted living residents with and without dementiaQuincy M Samus, Lawrence Mayer, Chiadi U Onyike, et al.
Journal of Alzheimer'S Disease : JAD|December 8, 2015
Empirically Defining Trajectories of Late-Life Cognitive and Functional DeclineHelen Hochstetler, Paula T Trzepacz, Shufang Wang, et al.
Journal of Applied Gerontology : the Official Journal of the Southern Gerontological Society|February 23, 2023
Economic Analysis of the Tailored Activity Program: A Nonpharmacological Approach to Improve Quality of Life in People Living With Dementia and their CaregiversLaura T Pizzi, Katherine M Prioli, Eric Jutkowitz, et al.
Schizophrenia Bulletin|June 2, 2025
Screening for Cognitive Decline in Psychotic Disorders in Midlife: Examining Scoring the Clinical Dementia Rating Using Longitudinal DataSean A P Clouston, Katherine Jonas, Constantine G Lyketsos, et al.
Alzheimer'S & Dementia (New York, N. Y.)|July 14, 2026
Heterogeneous responses to memantine in Alzheimer's disease: A precision medicine approach using iPSC modelsCristina Zivko, Ram Sagar, Waqar Ahmed, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|September 29, 2015
Oral glucose tolerance testing to modulate plasma amyloid levels: A novel biomarkerEsther S Oh, Christopher M Marano, Jeannie-Marie Leoutsakos, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|January 25, 2013
Systematic review of the effectiveness of pharmacologic interventions to improve quality of life and well-being in people with dementiaClaudia Cooper, Naaheed Mukadam, Cornelius Katona, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 6, 2011
Neuropsychiatric symptoms in Alzheimer's diseaseConstantine G Lyketsos, Maria C Carrillo, J Michael Ryan, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|June 13, 2019
Neuropsychiatric Symptoms as Risk Factors for Cognitive Decline in Clinically Normal Older Adults: The Cache County StudyMuhammad Haroon Burhanullah, JoAnn T Tschanz, Matthew E Peters, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|September 9, 2004
Cognitive response to pharmacological treatment for depression in Alzheimer disease: secondary outcomes from the depression in Alzheimer's disease study (DIADS)Cynthia A Munro, Jason Brandt, Jeannie-Marie E Sheppard, et al.
Pageof 40